A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis.

Reza RahmanzadehRiccardo GalbuseraPo-Jui LuErik BahnMatthias WeigelMuhamed BarakovicJonas FranzThanh D NguyenPascal SpincemailleSimona SchiaviAlessandro DaducciFrancesco La RosaMartina AbsintaPascal SatiMeritxell Bach CuadraErnst-Wilhelm RadueDavid LeppertJens KuhleLudwig KapposWolfgang BrückDaniel S ReichChristine StadelmannYi WangCristina Granziera

Published in: Annals of neurology (2022)

These results provide the first evidence that it is possible to distinguish chronic MS lesions in a clinical setting, hereby supporting with new biomarkers to develop and assess remyelinating treatments. ANN NEUROL 2022;92:486-502.

Keyphrases

multiple sclerosis
magnetic resonance imaging
mass spectrometry
white matter
contrast enhanced
ms ms
diffusion weighted imaging